TheraSphere Y-90 Glass Microspheres Receives FDA Approval Reports Boston Scientific
TheraSphere Y-90 Glass Microspheres is developed for the treatment of patients with hepatocellular carcinoma (HCC).
Fujitsu Concludes a Comprehensive Collaborative Research Agreement with National Cancer Center Japan: To Create New Services for Drug Development and Clinical Trials
Research draws from real-world data sources including electronic medical records.
Benefits Of Travelling For Surgery
One of the defining reasons medical tourism is so popular is because of the large savings on treatment, even after those seeking treatment have paid for flights and accommodation.
ACC, Novo Nordisk to Advance Care for People with Type 2 Diabetes, Cardiovascular Disease
ACC notes through the global UNITE (Multidisciplinary Teams In Cardiometabolic Care) program, clinicians across multiple specialties will receive the education and tools needed for an integrated approach to Type 2 diabetes and cardiovascular disease care.
SELUTION SLR Enrollment of 4 Clinical Studies to Commence: MedAlliance Raises over USD 50 Million from New Investor
The new investor is Trustar Capital (formerly known as CITIC Capital Partners).